Kirsten Egelund Holgaard, MSc

Kirsten Egelund Holgaard, MSc

Kirsten Egelund Holgaard holds a Bachelor of Industrial Medicine and a Master of Biomedicine with a master’s thesis on immunohistochemical assessment of effectiveness of Carnitine Palmitoyl Transferase 1 (CPT1) blocking in rat model of experimental autoimmune...
Anne Skøttrup Mørkholt, PhD

Anne Skøttrup Mørkholt, PhD

Dr. Mørkholt completed her doctorate at the Laboratory of Metabolism Modifying Medicine, Aalborg University with research into the connection between dysfunction of the lipid metabolism and CNS diseases, including multiple sclerosis and depression.
John Nieland, PhD

John Nieland, PhD

Dr. Nieland brings broad management experience, an in-depth research background and expertise in the development of biopharmaceuticals and coordination and development of clinical trials. He was previously director of research at Medigene AG and is co-founder of the...
Preben Bruun-Nyzell

Preben Bruun-Nyzell

Preben Bruun-Nyzell is an executive with more than 20 years international experience. In addition to his role in 2N Pharma, he is co-founder and CEO of the clinical stage vaccine company 2A Pharma and chairman of Apoglyx which specialises in medical applications of...